Establishment and Operation of Clinical Trial Data Monitoring Committees: Guidance for Clinical Trial Sponsors
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
March 28, 2006
December 3, 2021
47889110-d7ce-4f2a-92f8-0dabfa6effe3
Related Documents
Drug and Device Manufacturer Communications With Payors, Formulary Committees, and Similar Entities – Questions and Answers: Guidance for Industry and Review Staff
Guidance DocumentJune 13, 2018Center for Drug Evaluation and Research
Pharmacogenomic Data Submissions: Guidance for Industry
Guidance DocumentMarch 1, 2005Center for Drug Evaluation and Research
Cooperative Manufacturing Arrangements for Licensed Biologics: Guidance for Industry
Guidance DocumentNovember 28, 2008Center for Biologics Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.